Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Imbruvica, Rituxan Combination sNDA Accepted for Review by FDA

americanpharmaceuticalreviewJune 27, 2018

Tag: Imbruvica , Rituxan Combination , NDA

PharmaSources Customer Service